Gabelli & Co Investment Advisers’s Centessa Pharmaceuticals CNTA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,400	Closed	-$373K	–	325
2026 Q1	$373K	Buy	+9,400	New	+$240K	0.06%	190

Gabelli & Co Investment Advisers's CNTA Position: Q2 2026 in Review

Gabelli & Co Investment Advisers sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 9,400 shares — an estimated $373K sold.

Gabelli & Co Investment Advisers first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $373K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Gabelli & Co Investment Advisers reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 9,400 Centessa Pharmaceuticals shares in Q2 2026, an estimated $373K.
Gabelli & Co Investment Advisers first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Centessa Pharmaceuticals position peaked at $373K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.